Development and activation of regulatory T cells in the human fetus

European Journal of Immunology

Volumn 35, Issue 2, 2005, Pages 383-390

  Cupedo, Tom ^a   Nagasawa, Maho ^a   Weijer, Kees ^a   Blom, Bianca ^a   Spits, Hergen ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Fetal; Human; Lymph nodes; Regulatory T cells; Thymus

Indexed keywords

CD27 ANTIGEN; CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN EXPRESSION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FETUS; FETUS DEVELOPMENT; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOREACTIVITY; IMMUNOREGULATION; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; LYMPHOID ORGAN; MEMORY CELL; PERIPHERAL LYMPHOCYTE; PHASE TRANSITION; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; FEMALE; FETUS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LYMPHOID TISSUE; PREGNANCY; RECEPTORS, INTERLEUKIN-2; THYMUS GLAND;

EID: 14744287197     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425763     Document Type: Article

References (38)

1. Bach, J. F., Regulatory T cells under scrutiny. Nat. Rev. Immunol. 2003. 3: 189-198.
2. + regulatory T cells. Semin. Immunol. 2004. 16: 89-98.
3. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2002. 2: 389-400.
4. + regulatory T cells. Nat. Immunol. 2003. 4: 330-336.
5. Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F. and Ochs, H. D., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001. 27: 20-21.
6. Bennett, C. L., Brunkow, M. E., Ramsdell, F., O'Briant, K. C., Zhu, Q., Fuleihan, R. L., Shigeoka, A. O., Ochs, H. D. and Chance, P. F., A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA->AAUGAA) leads to the IPEX syndrome. Immunogenetics 2001. 53: 435-439.
7. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S. A., Wilkinson, J. E., Galas, D., Ziegler, S. F. and Ramsdell, F., Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001. 27: 68-73.
8. Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A. and Mauri, C., Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 2004. 200: 277-285.
9. Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin-Su, K., Ten, S., Sanz, M., Exley, M., Wilson, B., Porcelli, S. and Maclaren, N., Multiple immuno-regulatory defects in type-1 diabetes. J. Ciin. Invest. 2002. 109: 131-140.
10. +CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J. Immunol. 2004. 173: 1444-1453.
11. Stephens, L. A., Mottet, C., Mason, D. and Powrie, F., Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 2001. 31: 1247-1254.
12. Annunziato, F., Cosmi, L., Liotta, F., Lazzeri, E., Manetti, R., Vanini, V., Romagnani, P., Maggi, E. and Romagnani, S., Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J. Exp. Med. 2002. 196: 379-387.
13. Bensinger, S. J., Bandeira, A., Jordan, M. S., Caton, A. J. and Laufer, T. M., Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J. Exp. Med. 2001. 194: 427-438.
14. Apostolou, I., Sarukhan, A., Klein, L. and von Boehmer, H., Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 2002. 3: 756-763.
15. Spits, H., Development of alphabeta T cells in the human thymus. Nat. Rev. Immunol. 2002. 2: 760-772.
16. + regulatory thymocytes. Blood 2003. 102: 4107-4114.
17. Takahata, Y., Nomura, A., Takada, H., Ohga, S., Furuno, K., Hikino, S., Nakayama, H., Sakaguchi, S. and Hara, T., CD25(+)CD4(+) T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene. Exp. Hematol. 2004. 32: 622-629.
18. + T cells. Eur. J. Immunol. 2003. 33: 579-587.
19. + regulatory T cells. Eur. J. Immunol. 2002. 32: 1621-1630.
20. Pandey, A., Ozaki, K., Baumann, H., Levin, S. D., Puel, A., Farr, A. G., Ziegler, S. F., Leonard, W. J. and Lodish, H. F., Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat. Immunol. 2000. 1: 59-64.
21. + T cells in thymus, cord and adult blood. Immunology 2002. 106: 190-199.
22. Dieckmann, D., Plottner, H., Berchtold, S., Berger, T. and Schuler, G., Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J. Exp. Med. 2001. 193: 1303-1310.
23. high regulatory cells in human peripheral blood. J. Immunol. 2001. 167: 1245-1253.
24. Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J. and Enk, A. H., Identification and functional characterization of human CD4(+)CD25 (+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 2001. 193: 1285-1294.
25. + as well as CD25 regulatory T cells. Proc. Natl. Acad. Sci. USA 2002. 99: 13031-13036.
26. + counterparts. J. Immunol. 2004. 172: 6123-6128.
27. +) lineage. Eur. J. Immunol. 2003. 33: 1282-1291.
28. + regulatory T cell repertoire formation in response to varying expression of a neo-self-antigen. J. Immunol. 2004. 173: 236-244.
29. Fontenot, J. D. and Rudensky, A. Y., Molecular aspects of regulatory T cell development. Semin. Immunol. 2004. 16: 73-80.
30. + regulatory T cells. Immunology 2003. 109: 319-325.
31. - T cells. J. Clin. Invest. 2003. 112: 1437-1443.
32. + regulatory T cells in the steady state. J. Exp. Med. 2003. 198: 737-746.
33. Miller, J. F. A. P. and Morahan, G., Peripheral T cell tolerance. Annu. Rev. Immunol. 1992. 10: 51-69.
34. Macian, F., Im, S. H., Garcia-Cozar, F. J. and Rao, A., T cell anergy. Curr. Opin. Immunol. 2004. 16: 209-216.
35. Levy-Lahad, E. and Wildin, R. S., Neonatal diabetes mellitus, enteropathy, thrombocytopenia, and endocrinopathy: Further evidence for an X-linked lethal syndrome. J. Pediatr. 2001. 138: 577-580.
36. Gambineri, E., Torgerson, T. R. and Ochs, H. D., Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T cell homeostasis. Curr. Opin. Rheumatol. 2003. 15: 430-435.
37. Wildin, R. S., Smyk-Pearson, S. and Filipovich, A. H., Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. J. Med. Genet. 2002. 39: 537-545.
38. Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J. L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L. et al., X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001. 27: 18-20.